Description

Customized Micro-Dose MTP-131 (SS-31) Therapy

• MTP-131 (SS-31) is a Mitochondria Targeting Peptide therapy designed to support healthy cellular energy production and reduce oxidative stress.
• Helps protect and restore mitochondrial function, which may improve overall cellular performance.
• May support increased energy levels, physical recovery, and endurance.
• Potential benefits for cognitive function, focus, and mental clarity.
• Emerging research suggests support for cardiovascular and metabolic health.
• May help reduce fatigue associated with mitochondrial dysfunction and aging.
• Gaining attention as an innovative peptide therapy focused on optimizing the body’s natural energy systems at the cellular level.

Patients using MTP-131 commonly report benefits such as:

• Increased daily energy and reduced fatigue
• Improved exercise endurance and workout recovery
• Better mental clarity, focus, and cognitive performance
• Enhanced stamina and physical performance
• Reduced muscle soreness and quicker recovery after activity
• Improved sleep quality and overall sense of well-being
• Support for healthy aging and vitality
• Some patients report improved cardiovascular endurance and resilience

Individual results can vary, and while many of these effects are based on patient experience and early clinical research, larger studies are still ongoing to better define the full therapeutic benefits and long-term safety profile of SS-31 peptide therapy.

Who should not use Mitochondria Targeting Peptides?

• Pregnant or breastfeeding individuals, due to limited safety data
• Patients with active cancer or undergoing cancer treatment, unless approved by their oncology team
• Individuals with severe liver or kidney disease without medical supervision
• Anyone with a known allergy or sensitivity to peptide therapies or injectable compounds
• Patients taking multiple prescription medications that could interact with experimental therapies
• Individuals under 18 years old, unless specifically prescribed in a monitored clinical setting
• Anyone with unstable or serious medical conditions without the consent of their clinicians

This is a medical peptide therapy program administered by licensed clinicians in a telemedicine setting, we do not sell “Research Use Only” peptides. All associated medications come from licensed US pharmacies and are shipped directly to the patient of record with valid medical waiver and ID after a prescreening evaluation process. Any orders that do not meet the requirements set forth by our clinicians or subvert the waiver process in any way will be cancelled and refunded. To learn more about medical peptides and 503B compounding including associated risks and standards please visit FDA.gov – If you have questions about how our treatment process works please call our clinic directly.